retatrutide sleep apnea Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide Phase 3: TRIUMPH Program

Second, as the main analysis, we used a per-protocol approach to estimate the increased risk of SIS in GLP-1RA vs SGLT-2i users

When researchers used erythromycin (a prokinetic) to override the effects on stomach emptying, GLP-1's ability to lower glucose dropped [3]

Media Influence: Media, including advertisements, TV shows, and movies, often promote fair-skinned individuals as the epitome of beauty

Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R

A prospective case series study found that GLP-1RAs, such as liraglutide and exenatide, reduced the population of cutaneous T cells and the expression of IL-17 in skin lesions

When used responsibly, combining NAD and glutathione may support detoxification, antioxidant protection, and metabolic health